Investigational flu drug a near match for oseltamivir

Post Date: 
MedPage Today
. . . The virologic endpoints are interesting, but the bottom line is that people want to feel well more quickly, commented Natasha Chida, MD, of Johns Hopkins University School of Medicine in Baltimore, co-moderator of the IDWeek session.
Clearing the symptoms is important, "in terms of work force issues and the cost to society of having people off work," she told MedPage Today.
"It didn't seem that drug was much better than oseltamivir," she added, but investigating ways to get people back to work sooner is "very helpful." . . .